XML 162 R119.htm IDEA: XBRL DOCUMENT v3.20.2
Share-Based Compensation - Narrative (Details)
1 Months Ended 12 Months Ended
Jun. 30, 2020
CAD ($)
shares
Mar. 31, 2019
shares
$ / shares
Jun. 30, 2020
CAD ($)
shares
Jun. 30, 2019
CAD ($)
shares
Jun. 30, 2018
shares
Disclosure of terms and conditions of share-based payment arrangement [line items]          
Percentage of common shares issuable pursuant to compensation arrangements (shall not exceed) 10.00%   10.00%    
Options outstanding (in shares) 5,748,503   5,748,503 5,693,397 2,346,343
Exercise period 3 years 11 months 11 days        
Weighted average fair value of stock options granted (in CAD per share) | $ $ 25.26   $ 25.26 $ 63.36  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 376,296   376,296 169,195 179,167
Weighted average fair value of RSUs and DSUs granted (in CAD per share) | $ $ 37.82   $ 37.82 $ 96.24  
Stock options          
Disclosure of terms and conditions of share-based payment arrangement [line items]          
Aggregate share-based compensation expense | $     $ 43,700,000 $ 86,700,000  
RSUs          
Disclosure of terms and conditions of share-based payment arrangement [line items]          
Number of common shares, right to receive (in shares) 1   1    
Number of instruments reserved (in shares) 833,333   833,333    
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 360,098   360,098 166,778  
DSUs          
Disclosure of terms and conditions of share-based payment arrangement [line items]          
Instrument redemption period following termination 90   90    
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 16,198   16,198 2,417  
DSUs and RSUs          
Disclosure of terms and conditions of share-based payment arrangement [line items]          
Aggregate share-based compensation expense | $     $ 5,800,000 $ 5,300,000  
Top of range | DSUs          
Disclosure of terms and conditions of share-based payment arrangement [line items]          
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 83,333   83,333    
Strategic Advisor          
Disclosure of terms and conditions of share-based payment arrangement [line items]          
Options outstanding (in shares)   1,663,480      
Exercise price (in CAD per share) | $ / shares   $ 124.08      
Exercise period   7 years      
Vesting period   4      
Strategic Advisor | Stock options          
Disclosure of terms and conditions of share-based payment arrangement [line items]          
Aggregate share-based compensation expense | $     $ 4,300,000 $ 16,700,000